It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the ...

Transaction expected to facilitate enhanced focus on Xtant's core businesses Total consideration of approximately $19.2 million allows Xtant to reduce outstanding debt and improve liquidityBELGRADE, Mont., July 8, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that the company has entered into agreements to sell certain Coflex® and CoFi ...

Neuralink implants can currently control cursors and recreate mental images on a screen, but another goal recently showcased is turning brain waves into physical actions.In this demo, Neuralink, recorded neural signals that are creating movement through a Tesla Optimus arm. https://t.co/d9GKY1yE8F ...

RT DogeDesigner (@cb_doge)🚨BREAKING: Elon Musk says Neuralink’s visual implants could give humans the ability to see multispectral wavelengths, including infrared, ultraviolet, and even radar, essentially granting superhuman vision. https://t.co/oLsFcqkEoL ...

RT Tesla Owners Silicon Valley (@teslaownersSV)“In the next 6 to 12 months, we'll be doing our first implants for vision, where even if somebody is completely blind, we can write directly to the visual cortex.”Elon Musk https://t.co/XCbOl4Z3nk ...

Investor Day Welcome Investors' Day Agenda Welcome; Logistics; Agenda Raj Denhoy Corporate Overview Peter Caldini Motiva® USA Business Updates Jeff Ehrhardt US Breast Aesthetic - Panel Ben Newcott Breast Reconstruction Opportunity in the USA Jeff Ehrhardt US Breast Reconstruction - Panel Ben Newcott Unlocking New Markets - Panel Juan José Chacón-Quirós Management Q&A Topic Presenter/Moderator Innovation Pipeline Roberto de Mezerville GLP-1s and Plastic Surgery Juan José Chacón-Quirós Agenda Forward Looking ...

RT Ryan Tanaka (@RyanTanaka3)Neuralink is working on solving these brain/ spine problems:- Blindness- Paralysis- Hearing loss- Tinnitus- Memory loss- Depression- Insomnia- Extreme pain- Seizures- Anxiety- Addiction- Strokes- Brain damage- Neck pain- Back pain ...

Core Insights - Oak Hill Advisors (OHA) acted as the Administrative Agent and Lead Left Arranger for the private senior debt financing for Montagu Private Equity's acquisition of Tyber Medical, a prominent orthopedic device manufacturer [1][2] - The acquisition will merge Tyber Medical with Montagu's existing portfolio companies, Resolve Surgical Technologies and Intech Medical, to form a scaled contract development and manufacturing organization (CDMO) [2] - OHA's extensive experience in the CDMO sector enabled it to efficiently assess the financing opportunity [3] Company Insights - Tyber Medical specializes in orthopedic devices, providing FDA-cleared and CE-marked implants for spinal, extremity, and trauma markets, with over 50 systems released since its inception in 2012 [7] - Montagu Private Equity focuses on mid-market investments, particularly in businesses with essential products in growing markets, managing €14 billion in assets [8][9] - OHA has approximately $95 billion in assets under management across various credit strategies as of March 31, 2025, emphasizing long-term partnerships and customized credit solutions [5][6]

Lyra therapeutics (NASDAQ: LYRA ) is developing corticosteroid-eluting implants for treatment of chronic rhinosinusitis; LYR-210 for patients without prior surgery and LYR-220 for patients with prior ethmoid sinus surgery. A single therapy (easily placed at the ENT's office) providesAnalyst’s Disclosure:I/we have a beneficial long position in the shares of LYRA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving com ...